OGN vs XXII · P/E 3.4, rev $3.02B vs rev $7.0M
Organon & Co (OGN) versus 22nd Century Group Inc (XXII) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
22nd Century Group Inc (XXII) is a tobacco company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported XXII revenue for 2026-06-30 was $7.0M. Net income was -$6.6M. Revenue was up 69.8% from 2026-03-31 to 2026-06-30. XXII currently screens at market cap $1.9M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. XXII currently screens at market cap $1.9M.
Not investment advice. Open the OGN and XXII stock pages for the full models.
Not investment advice.